Targeting and imaging signature caveolar molecules in lungs.
A major goal of molecular medicine is to target imaging agents or therapeutic compounds to a single organ. Targeting imaging agents to a single organ could facilitate the high-resolution, in vivo imaging of molecular events. In addition, genetic and acquired diseases primary to a single organ, such as cystic fibrosis, tuberculosis, lung cancer, pulmonary fibrosis, pulmonary hypertension, and acute respiratory distress syndrome, could be specifically targeted in the lung. By targeting and concentrating imaging agents or therapeutics to the lungs, deleterious side effects can be avoided with greater efficacy at much lower dosages. Pathologic changes can be identified earlier and followed over time. In addition, therapeutics that have been abandoned due to toxicities may find renewed utility when coupled with specific targeting agents such as antibodies. To achieve these goals, distinct molecular signatures must be found for each organ or disease-state.
Massey
Kerri A
KA
Proteogenomics Research Institute for Systems Medicine, 11107 Roselle St., San Diego, CA 92121, USA.
Schnitzer
Jan E
JE
D015415:Biomarkers / Q000032:analysis; D021941:Caveolae / Q000502:physiology*; D004730:Endothelium, Vascular / Q000502:physiology* / Q000503:physiopathology*; D006801:Humans; D008168:Lung / Q000098:blood supply*; D008171:Lung Diseases / Q000175:diagnosis* / Q000503:physiopathology / Q000628:therapy; D008175:Lung Neoplasms / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy; D013058:Mass Spectrometry; D057054:Molecular Imaging; D020543:Proteome
D015415:Biomarkers; D020543:Proteome
Proc Natl Acad Sci U S A. 2002 Feb 19;99(4):1996-2001
11854497
Am J Clin Pathol. 1989 Aug;92(2):241-50
2667329
Proteomics. 2005 Jul;5(11):2718-28
15986331
Biochem Biophys Res Commun. 1994 Feb 28;199(1):11-9
8123001
Exp Cell Biol. 1989;57(4):185-92
2599260
Science. 2000 Aug 18;289(5482):1197-202
10947988
Nature. 1975 Aug 7;256(5517):495-7
1172191
J Cell Biol. 1994 Apr;125(1):87-97
8138577
Am J Physiol. 1999 Dec;277(6):H2222-32
10600840
J Virol. 2002 May;76(10):5266-70
11967340
Nature. 1996 Mar 28;380(6572):364-6
8598934
Science. 2001 Sep 28;293(5539):2449-52
11498544
J Proteome Res. 2002 Jul-Aug;1(4):317-23
12645887
J Proteome Res. 2006 Sep;5(9):2339-47
16944946
Dis Markers. 1990 Jul-Aug;8(4):179-90
2088634
Mol Immunol. 1987 Jul;24(7):699-705
3309626
J Biol Chem. 1999 Aug 13;274(33):23144-54
10438484
Nature. 1987 Jan 15-21;325(6101):253-7
3543687
Proc Natl Acad Sci U S A. 1987 Nov;84(22):7957-61
2446314
Expert Rev Proteomics. 2007 Feb;4(1):25-37
17288513
Mol Med Today. 1999 Jan;5(1):40-6
10088131
FASEB J. 1990 Sep;4(12):3040-8
2168327
J Nucl Med. 1989 Oct;30(10):1686-92
2552048
J Biol Chem. 1994 Dec 9;269(49):30745-8
7982998
Proc R Soc Lond B Biol Sci. 1967 Jan 31;167(1006):39-63
4382590
FASEB J. 2000 Apr;14(5):740-51
10744630
J Immunol. 1998 Aug 15;161(4):1829-36
9712050
J Biol Chem. 1989 Mar 25;264(9):4755-8
2925665
Microvasc Res. 1991 Sep;42(2):139-50
1943833
Cell. 2006 Dec 15;127(6):1265-81
17174899
J Cell Biol. 1985 Dec;101(6):2233-8
4066756
J Clin Invest. 1994 Aug;94(2):885-91
7518844
Drug Discov Today. 2002 Aug 1;7(15):815-22
12546969
J Vasc Res. 2009;46(4):311-24
19142011
J Cell Biol. 1998 Apr 6;141(1):101-14
9531551
Endothelium. 2003;10(3):167-78
13129820
Nature. 2004 Jun 10;429(6992):629-35
15190345
J Cell Sci. 1988 Jul;90 ( Pt 3):341-8
3075612
J Cell Biol. 1992 May;117(4):745-55
1577854
J Cell Biol. 1986 Apr;102(4):1304-11
3007533
Science. 1995 Sep 8;269(5229):1435-9
7660128
Am J Physiol. 1995 Jan;268(1 Pt 2):H48-55
7840297
Biochemistry. 1993 Dec 21;32(50):14009-14
8268179
EMBO J. 2002 Oct 1;21(19):5088-96
12356725
Neuroscience. 2008 Aug 13;155(2):423-38
18619525
Proc Natl Acad Sci U S A. 1994 Apr 12;91(8):3014-8
8159697
FASEB J. 1995 Jul;9(10):874-82
7615157
J Cell Biol. 1987 Dec;105(6 Pt 1):2603-12
3320050
Rev Neurosci. 2001;12(2):187-93
11392458
J Cell Physiol. 1993 Sep;156(3):610-8
8360263
Ser Haematol. 1973;6(4):453-5
4794930
Mol Cell Proteomics. 2005 Oct;4(10):1487-502
15979981
J Clin Invest. 1973 Nov;52(11):2745-56
4355998
Nature. 2003 Dec 4;426(6966):570-4
14654843
Science. 2008 Sep 26;321(5897):1758-61
18818332
Nat Biotechnol. 2007 Apr;25(4):431-2
17420750
J Clin Invest. 1998 Jul 15;102(2):430-7
9664085
Blood. 1985 Oct;66(4):816-23
2412618
Arteriosclerosis. 1983 Sep-Oct;3(5):403-12
6354160
Adv Drug Deliv Rev. 2001 Jul 28;49(3):265-80
11551399
Nat Cell Biol. 2001 May;3(5):473-83
11331875
Hum Pathol. 1987 Mar;18(3):234-9
3546072
Cancer J. 2000 May;6 Suppl 3:S218-24
10874491
J Cell Biol. 1992 Dec;119(6):1507-13
1334960
Am J Physiol. 1988 Mar;254(3 Pt 2):H425-37
3279821
J Membr Biol. 1989 Mar;107(3):277-86
2716048
J Biol Chem. 1999 May 14;274(20):14176-87
10318836
J Nucl Med. 1991 Mar;32(3):453-60
1848608
Am J Physiol. 1997 Mar;272(3 Pt 1):L461-70
9124603
Mol Cell Proteomics. 2007 Sep;6(9):1560-73
17565973
Science. 1985 Jun 14;228(4705):1315-7
4001944
J Chromatogr A. 2005 Jun 24;1079(1-2):24-40
16038288
Anal Chem. 2002 Sep 15;74(18):4741-9
12349978
Cancer Cells. 1991 Mar;3(3):77-85
1711364
J Virol. 2001 Nov;75(22):10880-91
11602728
J Cell Biol. 1968 May;37(2):244-76
5656394
Science. 1996 Oct 11;274(5285):239-42
8824187
Cancer Cell. 2007 Jun;11(6):539-54
17560335
Mol Cell Proteomics. 2002 May;1(5):376-86
12118079
Dev Biol. 1981 May;84(1):183-92
7250491
J Biol Chem. 1995 Jun 16;270(24):14399-404
7782301
Anal Chem. 2004 Jul 15;76(14):4193-201
15253663
Nat Biotechnol. 2007 Mar;25(3):327-37
17334358
J Cell Biochem. 2006 Sep 1;99(1):117-25
16598772
Nat Biotechnol. 2003 Apr;21(4):392-8
12652312
J Cell Biol. 1997 Sep 8;138(5):1117-24
9281588
J Cell Biol. 1974 Jan;60(1):128-52
4129076
Int J Cancer. 1986 Oct 15;38(4):481-8
3531031
Nat Med. 1996 Apr;2(4):482-4
8597963
Protein Sci. 1998 Apr;7(4):1029-38
9568909
Biochem Biophys Res Commun. 2000 Sep 24;276(2):756-61
11027543
Blood Vessels. 1987;24(1-2):11-23
3032311
J Cell Biol. 1994 Dec;127(5):1199-215
7962085
Mol Cell Proteomics. 2009 Jun;8(6):1219-35
19155209
Nat Biotechnol. 2004 Aug;22(8):985-92
15258593
J Nucl Med. 2008 Jan;49(1):103-11
18077519
Mol Cell Proteomics. 2005 Sep;4(9):1265-72
15958392
Eur J Cell Biol. 1990 Aug;52(2):241-51
2081527
J Cell Biol. 1998 Apr 6;141(1):85-99
9531550
Immunol Rev. 1999 Apr;168:13-22
10399061
J Cell Biol. 1983 Jul;97(1):153-65
6190818
Cell. 1992 Feb 21;68(4):673-82
1739974
Proteomics. 2005 Aug;5(12):3035-9
16003826
J Virol. 1976 Aug;19(2):620-36
183018
Blood. 2008 Mar 15;111(6):3024-33
18182571
Proc Natl Acad Sci U S A. 2006 Jan 10;103(2):407-12
16384919
Mol Cell Proteomics. 2006 Apr;5(4):589-607
16399765
Pharmacol Rev. 2002 Sep;54(3):431-67
12223531
Nat Methods. 2005 Apr;2(4):291-8
15782212
Nat Med. 2003 Jan;9(1):123-8
12514725
Microvasc Res. 1979 Mar;17(2):107-17
449718
J Cell Physiol. 1988 Sep;136(3):398-410
3170638
Mol Cell Proteomics. 2008 Dec;7(12):2399-409
18676994